I. Fernandez (München, Germany), L. Fregonese (London, United Kingdom)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Association of laboratory markers with oxygen saturation and radiological findings in hospitalized COVID-19 patients
D. Mijakoski (Skopje, North Macedonia), Z. Markovska (Skopje, North Macedonia), I. Meshkova (Skopje, North Macedonia), S. Stoleski (Skopje, North Macedonia), J. Minov (Skopje, North Macedonia), J. Karadzinska-Bislimovska (Skopje, North Macedonia)
|   |
?hemiluminescent activity of blood phagocytes in patients with covid-19.
A. Lazareva (Krasnoyarsk, Russian Federation), O. Kolenchukova (Krasnoyarsk, Russian Federation), S. Smirnova (Krasnoyarsk, Russian Federation), V. Melder (Krasnoyarsk, Russian Federation), S. Tereshchenko (Krasnoyarsk, Russian Federation)
| |
Prospective biochemical and hematological markers to differentiation severe from non-severe COVID-19 disease
M. DOBRIN (IASI, Romania), O. Rohozeanu (IASI, Romania), R. Crisan-Dabija (IASI, Romania), R. Cernat (IASI, Romania), I. Buculei (IASI, Romania), R. Cernat (IASI, Romania), E. Popa (IASI, Romania), A. Trofor (IASI, Romania)
| |
Dynamics of the intensity of the immune response in COVID-19
E. Makarova (Nizhny Novgorod, Russian Federation), N. Lyubavina (Nizhny Novgorod, Russian Federation), M. Milyutina (Nizhny Novgorod, Russian Federation), I. Polyakova (Nizhny Novgorod, Russian Federation), E. Nekaeva (Nizhny Novgorod, Russian Federation), E. Galova (Nizhny Novgorod, Russian Federation), . Odintsov (Nizhny Novgorod, Russian Federation), N. Menkov (Nizhny Novgorod, Russian Federation)
| |
Hematological changes in COVID-19 and their association with the severity of the disease
A. Allouche (Tunis, Tunisia), J. Ben Amar (Tunis, Tunisia), K. Echi (Tunis, Tunisia), K. Hemissi (Tunis, Tunisia), H. Zaibi (Tunis, Tunisia), E. Ben Jemia (Tunis, Tunisia), H. Aouina (Tunis, Tunisia)
| |
Laboratory, functional and imaging changes in the follow-up of hospitalized patients with COVID 19
P. Titorenkov (Sofia, Bulgaria), M. Encheva (Sofia, Bulgaria), S. Zabadanova (Sofia, Bulgaria), E. Naseva (Sofia, Bulgaria)
| |
Neutrophil-to-lymphocyte, platlet-to-lymphocyte ratio and adiposityin early COVID -19
R. Cherneva (Sofia, Bulgaria), Z. Cherneva (Sofia, Bulgaria)
| |
Can Exhaled Nitric Oxide Be a Biomarker for Hospitalized and Post-COVID-19 Patients?
S. Ferreira (Santos, Brazil), W. S Fernandes (Santos, Brazil), R. C A Ferreira (Santos, Brazil), P. B Fialho (São José dos Campos, Brazil), C. E R Santos (São José dos Campos, Brazil), L. M Araujo (São José dos Campos, Brazil), L. M B R Santos (São José dos Campos, Brazil), M. A R Brandao-Rangel (Santos, Brazil), C. R Frison (São José dos Campos, Brazil), R. P Vieira (Santos, Brazil)
| |
CT patterns of lung damage and prognosis markers for the course of a new coronavirus infection COVID-19 in persons with comorbidity
V. Nevzorova (Vladivostok (Primorsky Krai), Russian Federation), A. Sakovskaia (Vladivostok (Primorsky Krai), Russian Federation), M. Ermolitskaya (Vladivostok (Primorsky Krai), Russian Federation), A. Simakova (Vladivostok (Primorsky Krai), Russian Federation), E. Novitskaya (Vladivostok (Primorsky Krai), Russian Federation)
| |
Impact of Covid-19 Pneumonia on Pulmonary Function, Functional Exercise Capacity and Quality of Life
A. Dilektasli (Bursa, Turkey), N. Ozturk (Bursa, Turkey), A. Odabas (Bursa, Turkey), E. Demirdogen (Bursa, Turkey), A. Ursavas (Bursa, Turkey), F. Coskun (Bursa, Turkey), O. Aydin Guclu (Bursa, Turkey), D. Ediger (Bursa, Turkey), E. Uzaslan (Bursa, Turkey)
| |
COVID-19 and obesity: specific clinical and laboratory features
N. Chichkova (Moscow, Russian Federation), A. Buchneva (Moscow, Russian Federation)
| |
Neutrophil-Lymphocyte and Neutrophil-Platelet Ratio during covid-19 infection: association with the occurrence of thromboembolic events
m. safa (ariana, Tunisia), M. Sarra (ariana, Tunisia), N. Imen (ariana, Tunisia), H. Sonia (ariana, Tunisia), R. Hajer (ariana, Tunisia), C. Nawel (ariana, Tunisia)
| |
Cerebral venous thrombosis in Covid-19
A. Saidani (Sfax, Tunisia), N. Kallel (Sfax, Tunisia), R. Khemekhem (Sfax, Tunisia), N. Moussa (Sfax, Tunisia), R. Gargouri (Sfax, Tunisia), W. Feki (Sfax, Tunisia), S. Kammoun (Sfax, Tunisia)
| |
Late Breaking Abstract - Breathlessness post COVID-19 despite improvement in cardiopulmonary health
M. Cassar (Oxford, United Kingdom), N. Petousi (Oxford, United Kingdom), L. Ho (Oxford, United Kingdom), N. Talbot (Oxford, United Kingdom), A. Lewandowski (Oxford, United Kingdom), M. Mahmod (Oxford, United Kingdom), E. Tunnicliffe (Oxford, United Kingdom), C. Xie (Oxford, United Kingdom), S. Piechnik (Oxford, United Kingdom), V. Ferreira (Oxford, United Kingdom), D. Holdsworth (Oxford, United Kingdom), S. Neubauer (Oxford, United Kingdom), B. Raman (Oxford, United Kingdom)
| |
Late Breaking Abstract - COVID-19 risk perception and vaccine willingness among healthcare workers in specialized respiratory clinics in Germany
M. Presotto (Heiderberg, Germany), R. Jörres (Munich, Germany), W. Gesierich (Munich, Germany), J. Bullwinkel (Grosshansdorf, Germany), K. Rabe (Grosshansdorf, Germany), K. Schultz (Bad Reichenhall, Germany), F. Kaestner (Wangen, Germany), D. Harzheim (Wangen, Germany), M. Kreuter (Heidelberg, Germany), F. Herth (Heidelberg, Germany), F. Trudzinski (Heiderberg, Germany)
| |
Late Breaking Abstract - Long COVID-19 symptoms including fatigue are more frequent in females independently of COVID-19 treatment
S. Sohrab (Duisburg, Germany), D. Westhölter (Essen, Germany), C. Taube (Essen, Germany), N. Mülleneisen (Leverkusen, Germany), M. Joest (Bonn, Germany), W. Roemer (Krefeld, Germany), S. Joerger-Tuti (Siegburg, Germany), W. Wende (Cologne, Germany)
| |
Late Breaking Abstract - 12-month lung clinical and functional consequences in patients with severe COVID-19
G. Abdullaeva (Moscow, Russian Federation), M. Mustafina (Moscow, Russian Federation), S. Avdeev (Moscow, Russian Federation), G. Gordina (Moscow, Russian Federation)
| |
Late Breaking Abstract - Development of a multivariate model for clinical prediction in COVID 19 infected patients .
A. Camelier (Salvador (BA), Brazil), A. Meireles (Salvador (BA), Brazil), A. Oliveira (Salvador (BA), Brazil), V. Araujo (Salvador (BA), Brazil), M. Santos (Salvador (BA), Brazil), L. Correia (Salvador (BA), Brazil)
| |
Late Breaking Abstract - Retrospective observational analysis of platypnea- orthodeoxia syndrome (POS) in long COVID over 5 months at a pulmonary medicine unit
T. Athavale (Mumbai, India), A. Athavale (Mumbai, India), K. Joshi (Mumbai, India), S. Ravindran (Mumbai, India), A. Trehan (Mumbai, India), P. Khupse (Mumbai, India), M. Jansari (Mumbai, India), S. Karpe (Mumbai, India)
| |